Case Linked Antisynthetase Syndrome to Renal Damage
A 2026 report documented a patient whose rare condition triggered focal segmental glomerulosclerosis.
Updated on Sept. 21, 2026 in Arthritis
A case report published August 25, 2026, detailed the medical history of a 48-year-old woman diagnosed with anti-Jo-1-positive antisynthetase syndrome. The patient suffered from systemic muscle weakness and arthralgia alongside focal segmental glomerulosclerosis, a kidney disorder.
Why it matters
The findings highlight a rare but critical intersection between idiopathic inflammatory myopathies and renal impairment. This case illustrates the importance of monitoring for kidney involvement in patients presenting with anti-Jo-1 antibodies.
A case report identified renal involvement in a patient with an initial proteinuria level of 2.657 g/day and serum creatinine of 129 μmol/L. Analysis revealed that 51% to 75% of the patient's capillary loops exhibited foot process effacement.
The players
Archives of Medical Science
This peer-reviewed medical journal serves as the platform for publishing specialized clinical research and case reports.
The details
The patient presented with a temperature of 40.0 °C, severe muscle weakness, and elevated creatine kinase levels of 1398 U/L. Diagnostic testing, including a renal biopsy and a myositis-specific antibody panel, confirmed the diagnosis before the patient began a regimen of 32 mg daily methylprednisolone and 1 mg twice-daily tacrolimus.
Timeline
August 25, 2026, marked the publication date of the case report in the Archives of Medical Science.
After 3 months of treatment, the patient showed improvement in creatinine and urinary protein levels.
After 6 months of treatment, the patient achieved stable renal function and normalized muscle enzymes.
The Big Picture
This case study extends the clinical understanding of how the diagnostic criteria for idiopathic inflammatory myopathies account for multisystem involvement. The findings underscore a need to broaden the diagnostic scope when patients present with both autoimmune markers and renal abnormalities.
Patients diagnosed with antisynthetase syndrome may require closer coordination between rheumatology and nephrology teams to monitor for potential kidney damage. Regular screening for proteinuria and creatinine fluctuations could be vital for those exhibiting systemic symptoms.
The takeaway
Clinical awareness of potential renal complications in autoimmune myositis cases can facilitate earlier intervention and improved outcomes. Patients should ensure their care team is aware of all co-occurring symptoms, including changes in urinary health.
Further reading
For broader context on immune-related joint and tissue inflammation, explore our Arthritis section.
Source note: This article includes information reported by Renal and Urology News.
